HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cryptococcal meningoencephalitis in a patient with Hodgkin's lymphoma: successful treatment with fluconazole.

Abstract
The authors report a case of cryptococcal meningoencephalitis in a 22-year-old male with Hodgkin's disease at third stage B. Cryptococcus neoformans was isolated from cerebral spinal fluid (CSF) and blood specimens. Latex antigen agglutination tests and India ink preparations also were positive for this pathogenic yeast. Drug treatment for a week with 20 mg i.v./day of amphotericin B in combination with 2.5 g i.v./day of 5-fluorocytosine did not lead to any improvement in the patient. The patient became asymptomatic after the first week of treatment with a daily dose of 400 mg of fluconazole, administered intravenously. After two months of this regimen, all laboratory tests on CSF and blood specimens were negative.
AuthorsG Bolignano, G Chindemi, G Criseo
JournalMycoses (Mycoses) 1991 Jan-Feb Vol. 34 Issue 1-2 Pg. 63-5 ISSN: 0933-7407 [Print] Germany
PMID1922191 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Fluconazole
Topics
  • Adult
  • Fluconazole (therapeutic use)
  • Hodgkin Disease (complications)
  • Humans
  • Male
  • Meningitis, Cryptococcal (drug therapy, etiology)
  • Meningoencephalitis (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: